SC 13G/A: Replimune Group, Inc.
Ticker: REPL · Form: SC 13G/A · Filed: 2024-04-10T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Replimune Group, Inc..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0000093751-24-000577 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000093751-24-000577 Filing Date 2024-04-10 Accepted 2024-04-10 09:48:48 Documents 1 Document Format Files Seq Description Document Type Size 1 Replimune_Group_Inc.txt SC 13G/A 8361 Complete submission text file 0000093751-24-000577.txt 10283 Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000 STATE STREET CORP (Filed by) CIK : 0000093751 (see all company filings) EIN. : 042456637 | State of Incorp.: MA | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6022 State Commercial Banks (CF Office: 02 Finance) Mailing Address 500 UNICORN PARK WOBURN MA 01801 Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600 Replimune Group, Inc. (Subject) CIK : 0001737953 (see all company filings) EIN. : 822082553 | State of Incorp.: DE | Fiscal Year End: 0331 Type: SC 13G/A | Act: 34 | File No.: 005-90574 | Film No.: 24834413 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)